Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.
17-Nov-15 King's College Hospital has become the clinical partner for the first Indo UK Institute of Health, in New Chandigar, India. Backed by up to GBP100 mn of private investment, the project is the first of 11 which will see hospitals, nursing schools and medical colleges developed across India. The initiative will eventually amount to a GBP1 bn investment. [image: GOV UK]Read More
05-Nov-15 Australia's Ramsay Health Care has struck a joint venture agreement to open a string of high quality international hospitals in China's Pearl River Delta. The JV is with Jinan University No.1 Affiliated Hospital, also known as Guangzhou Overseas Chinese Hospital, and has the support of the Chinese government. [image: The Sydney Morning Herald]Read More
16-Nov-15 An OECD review of Australia's health system said that it was performing "remarkably well" despite its "fragmented nature" and the "sometimes strained" relationship between federal, state and territory governments over health funding. While Australia had improved its standards, it also mentioned: "A surprising lack of data on the quality and outcomes of care." [image: Merimbula News]Read More
16-Nov-15 In May 2015, the People's Friendship University of Russia (PFUR or RUDN), which has students from 152 countries, established a school of medical information and telemedicine. There are few doctors in Russia who know how to run telemedicine centers, and RUDN is aiming to equip its students with this knowledge. [image: Russian Beyond The Headlines / Press Photo]Read More
16-Nov-15 Japan, with sales of USD115, accounts for 10% of the global pharma market, compared with 38% for the US and 21% for Europe. Lupin is the only Indian company in Japan's generics market. But now Sun Pharmaceuticals is planning to acquire Novartis' Japanese drug portfolio. Other Indian generics makers, including Dr Reddy’s and Glenmark, are also exploring options. [image: Bloomberg]Read More
GGM is a research and advisory firm helping clients grow profitably in international markets.
We believe the only way to understand a market properly is on the ground. Intelligence from our in-country consultants gives you a competitive advantage in China, Asia, Latin America, the Middle East, Africa and other opportunity areas.
Our clients benefit from accurate data, reliable insights and strategic advice, giving them the confidence to make better business decisions and succeed in their global growth markets.
Enter your work email to stay up to date on the latest news and insights from GGM.
Get in touch to discuss your growth markets research and advisory needs: